mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.04 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.04 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.04 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.04 |